can you take glp-1 while breastfeeding meds like Ozempic® and Wegovy® are everywhere — but what if can you be on a

However, several clinical considerations may influence selection: Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use any GLP-1 receptor agonist

In March 2026, Structure reported 44-week topline data from the ACCESS II Phase 2 study, showing placebo-adjusted weight loss of up to 16.3%, which the company described as the highest efficacy demonstrated among oral GLP-1 receptor agonists at that time point

Individualising medicines use for people with type 2 diabetes (NG28 prescribing guide)

One coalition, Save Peptides, warned its followers: Our basic human rights to access alternative medical care using regenerative peptides is being stripped away by the FDA. A lawsuit brought by a large compounding pharmacy alleged that regulators had skipped legally required steps when adding peptides to FDAs list of high-risk substances

I could see a lot of translational outcomes leveraging this new understanding.